Drugs / Tinzaparine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT06845423 | May 2025 → May 2028 expected | venous thromboembolism | University Hospital, Brest | Recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04536272 Comparator | Oct 2020 → Mar 2025 | heart failure, hemorrhagic disease, respiratory failure, thrombotic disease | University Medical Center Groningen | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tinzaparine | “Tinzaparine 3500 UI” NCT06845423 ↗1“Tinzaparine” NCT04536272 ↗ |